Jump to contentJump to search

Bioavailable central nervous system disease-modifying therapies for multiple sclerosis.
Hartung et al., Front Immunol. 2023

Hans-Peter Hartung, Bruce A C Cree, Michael Barnett, Sven G Meuth, Amit Bar-Or, Lawrence Steinman.

Bioavailable central nervous system disease-modifying therapies for multiple sclerosis.

Front Immunol. 2023 Nov 29:14:1290666. doi: 10.3389/fimmu.2023.1290666. eCollection 2023. PubMed ID: 38162670

 

Further Information:

PubMed

Hans-Peter Hartung

Sven Meuth

Kategorie/n: NND-Publikationen
Responsible for the content: